Hospital de Jerez de la Frontera; Servicio de Hematologia
Jerez De La Frontera, Cadiz, Spain
University hospital in Jerez de la Frontera
Ctra. Trebujena, s/n, 11407 Jerez de la Frontera, Cádiz
About Hospital de Jerez de la Frontera; Servicio de Hematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital de Jerez de la Frontera; Servicio de Hematologia
During the past decade, Hospital de Jerez de la Frontera; Servicio de Hematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
2000-12-01
2004-01-01
Completed
431
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
2000-09-01
2003-10-01
Completed
446
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
2001-09-01
2004-04-01
Completed
633
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
2002-10-01
2014-07-01
Completed
2,305
Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure
2003-04-01
2008-07-01
Completed
2,331
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
2002-01-01
Completed
3,000
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
2003-04-01
Withdrawn
300
ARISE - Aggressive Reduction of Inflammation Stops Events
2003-06-01
2006-12-01
Unknown status
6,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital de Jerez de la Frontera; Servicio de Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital de Jerez de la Frontera; Servicio de Hematologia" are
"Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Hospital de Jerez de la Frontera; Servicio de Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital de Jerez de la Frontera; Servicio de Hematologia
Most popular intervention types in "Hospital de Jerez de la Frontera; Servicio de Hematologia" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Chemotherapy (Induction Period)" (1 trials), "Cyclophosphamide" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital de Jerez de la Frontera; Servicio de Hematologia
The vast majority of trials in "Hospital de Jerez de la Frontera; Servicio de Hematologia" are
2 trials for "All" genders.
Clinical Trials Status at Hospital de Jerez de la Frontera; Servicio de Hematologia
Currently, there are NaN active trials in "Hospital de Jerez de la Frontera; Servicio de Hematologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital de Jerez de la Frontera; Servicio de Hematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Jerez de la Frontera; Servicio de Hematologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".